NCT01024400View on ClinicalTrials.gov

Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

July 31, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

Non-adjuvanted A(H1N1)v influenza vaccine

15 mcg HA/0.5 ml

Trial Locations (5)

25030

CHU de Besançon-Hôpital Saint-Jacques, Besançon

35056

Hôpital Sud de Rennes, Rennes

75679

Groupe hospitalier Cochin Saint Vincent de Paul, Paris

75935

Hôpital Robert Debré, Paris

92141

Hôpital Antoine Béclère, Clamart

Sponsors

Collaborators (1)

MCM Vaccines B.V.
All Listed Sponsors
collaborator

MCM Vaccines B.V.

INDUSTRY

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT01024400 - Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women | Biotech Hunter | Biotech Hunter